RB
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity | Immunity | 2026 | 2 | 0 | |||
| Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy | Cell | 2024 | 1,002 | 403 | |||
| A neutrophil response linked to tumor control in immunotherapy | Cell | 2023 | 89 | 123 | |||
| Dendritic cells direct circadian anti-tumour immune responses | Nature | 2023 | 803 | 229 | |||
| CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers | Science | 2023 | 804 | 2 | |||
| Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity | Journal for immunotherapy of cancer | 2023 | 47 | 29 | |||
| Macrophage-Targeted Therapy Unlocks Antitumoral Cross-talk between IFNg-Secreting Lymphocytes and IL12-Producing Dendritic Cells | Cancer immunology research | 2022 | 199 | 59 | |||
| Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy | Science Immunology | 2021 | 470 | 1,018 | |||
| Diagnostic challenges and successful organ-preserving therapy in a case of secretory carcinoma of minor salivary glands | Cancer Reports | 2021 | 197 | 187 | |||
| Tumor-infiltrating dendritic cell states are conserved across solid human cancers | Journal of Experimental Medicine | 2021 | 299 | 515 |
